PharmaCorp Rx Statistics

Total Valuation

PharmaCorp Rx has a market cap or net worth of CAD 57.07 million. The enterprise value is 45.36 million.

Market Cap	57.07M
Enterprise Value	45.36M

Important Dates

The last earnings date was Thursday, April 17, 2025.

Earnings Date	Apr 17, 2025
Ex-Dividend Date	n/a

Share Statistics

PharmaCorp Rx has 115.30 million shares outstanding. The number of shares has increased by 303.02% in one year.

Current Share Class	n/a
Shares Outstanding	115.30M
Shares Change (YoY)	+303.02%
Shares Change (QoQ)	+3.87%
Owned by Insiders (%)	13.58%
Owned by Institutions (%)	n/a
Float	99.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.85
PB Ratio	1.87
P/TBV Ratio	4.16
P/FCF Ratio	483.34
P/OCF Ratio	456.69
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-44.79
EV / Sales	7.83
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	384.16

Financial Position

The company has a current ratio of 8.59, with a Debt / Equity ratio of 0.03.

Current Ratio	8.59
Quick Ratio	7.79
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	8.07
Interest Coverage	-111.38

Financial Efficiency

Return on equity (ROE) is -6.40% and return on invested capital (ROIC) is -5.88%.

Return on Equity (ROE)	-6.40%
Return on Assets (ROA)	-5.29%
Return on Invested Capital (ROIC)	-5.88%
Return on Capital Employed (ROCE)	-4.74%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.31
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +133.33% in the last 52 weeks. The beta is -5.17, so PharmaCorp Rx's price volatility has been lower than the market average.

Beta (5Y)	-5.17
52-Week Price Change	+133.33%
50-Day Moving Average	0.50
200-Day Moving Average	0.57
Relative Strength Index (RSI)	51.62
Average Volume (20 Days)	12,164

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PharmaCorp Rx had revenue of CAD 5.79 million and -1.01 million in losses. Loss per share was -0.01.

Revenue	5.79M
Gross Profit	2.18M
Operating Income	-1.59M
Pretax Income	-1.16M
Net Income	-1.01M
EBITDA	-1.35M
EBIT	-1.59M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 12.89 million in cash and 953,077 in debt, giving a net cash position of 11.93 million or 0.10 per share.

Cash & Cash Equivalents	12.89M
Total Debt	953,077
Net Cash	11.93M
Net Cash Per Share	0.10
Equity (Book Value)	30.57M
Book Value Per Share	0.26
Working Capital	12.88M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 124,968 and capital expenditures -6,890, giving a free cash flow of 118,078.

Operating Cash Flow	124,968
Capital Expenditures	-6,890
Free Cash Flow	118,078
FCF Per Share	0.00

Full Cash Flow Statement

Margins

Gross margin is 37.69%, with operating and profit margins of -27.41% and -17.48%.

Gross Margin	37.69%
Operating Margin	-27.41%
Pretax Margin	-19.97%
Profit Margin	-17.48%
EBITDA Margin	-23.23%
EBIT Margin	-27.41%
FCF Margin	2.04%

Dividends & Yields

PharmaCorp Rx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-303.02%
Shareholder Yield	-303.02%
Earnings Yield	-1.77%
FCF Yield	0.21%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PharmaCorp Rx has an Altman Z-Score of 8.61.

Altman Z-Score	8.61
Piotroski F-Score	n/a